US 7,473,699 B2
3-cyclyl-5-(nitrogen-containing 5-membered ring)methyl-oxazolidinone derivatives and their use as antibacterial agents
Michael Barry Gravestock, Waltham, Mass. (US); Neil James Hales, Maccleslesfield (United Kingdom); Folkert Reck, Waltham, Mass. (US); Fei Zhou, Waltham, Mass. (US); Paul Robert Fleming, Waltham, Mass. (US); Daniel Robert Carcanague, Waltham, Mass. (US); and Marc Michel Girardot, Atlanta, Ga. (US)
Assigned to AstraZeneca AB, Sodertalje (Sweden)
Appl. No. 10/506,020
PCT Filed Feb. 25, 2003, PCT No. PCT/GB03/00785
§ 371(c)(1), (2), (4) Date Aug. 26, 2004,
PCT Pub. No. WO03/072575, PCT Pub. Date Sep. 04, 2003.
Claims priority of provisional application 60/360957, filed on Feb. 28, 2002.
Prior Publication US 2005/0119292 A1, Jun. 02, 2005
This patent is subject to a terminal disclaimer.
Int. Cl. A61K 31/42 (2006.01); C07D 263/00 (2006.01)
U.S. Cl. 514—376  [548/229] 7 Claims
 
1. A compound of the formula (I), or a pharmaceutically acceptable salt, or an in-vivo hydrolysable ester thereof,

OG Complex Work Unit Drawing
wherein
—N-HET is selected from structures I(d) to (If):

OG Complex Work Unit Drawing
R1 is a (1-4C)alkyl group;
Q is selected from Q1 to Q6:

OG Complex Work Unit Drawing
R2 and R3 are independently selected from H, F, Cl, CF3, OMe, SMe, Me and Et;
T is selected from the groups (TA) to (TE);
(TA) T is selected from the following groups:
(TAa) AR1 or AR3; or
(TAb) a group of formula (TAb1) to (TAb6):

OG Complex Work Unit Drawing
wherein:
R6 is independently selected from hydrogen, (1-4C)alkyl, (1-4C)alkoxycarbonyl, (1-4C)alkanoyl, carbamoyl, and cyano;
R4 and R5 are independently selected from hydrogen, halo, trifluoromethyl, cyano, azido, nitro, (1-4C)alkoxy, (1-4C)alkylS(O)q— (q is 0, 1, or 2), (1-4C)alkanoyl, (1-4C)alkoxycarbonyl, benzyloxy-(1-4C)alkyl, (2-4C)alkanoylamino, hydroxyimino, (1-4C)alkoxyimino, —CONRcRv, and —NRcRv wherein any (1-4C)alkyl group contained in R4 and R5 is optionally substituted with up to three substituents independently selected from hydroxy and azido (excluding C1 of an alkoxy group and geminal disubstitution), oxo, trifluoromethyl, cyano, nitro, (1-4C)alkoxy, (2-4C)alkanoyloxy, hydroxyimino, (1-4C)alkoxyimino, (1-4C)alkylS(O)q— (q is 0, 1, or 2), (1-4C)alkylSO2—NRv-, (1-4C)alkoxycarbonyl, —CONRcRv, and —NRcRv (excluding C1 of an alkoxy group and geminal disubstitution); wherein Rv is hydrogen or (1-4C)alkyl;
R4 and R5 may further be independently selected from (1-4C)alkyl {optionally substituted with up to three substituents independently selected from hydroxy or azido (excluding geminal disubstitution), oxo, trifluoromethyl, cyano, nitro, (1-4C)alkoxy, (2-4C)alkanoyloxy, hydroxyimino, (1-4C)alkoxyimino, (1-4C)alkylS(O)q— (q is 0, 1, or 2), (1-4C)alkylSO2—NRv-, (1-4C)alkoxycarbonyl, —CONRcRv, and —NRcRv (excluding geminal disubstitution); wherein Rv is hydrogen or (1-4C)alkyl}; and any (1-4C)alkyl group contained in the immediately preceding optional substituents (when R4 and R5 are independently (1-4C)alkyl) is itself optionally substituted with up to three substituents independently selected from hydroxy (excluding C1 of an alkoxy group and geminal disubstitution), oxo, trifluoromethyl, cyano, nitro, (1-4C)alkoxy, (2-4C)alkanoyloxy, hydroxyimino, (1-4C)alkoxyimino, (1-4C)alkylS(O)q— (q is 0, 1, or 2), (1-4C)alkylSO2NRv-, (1-4C)alkoxycarbonyl, —CONRcRv, and —NRcRv (excluding C1 of an alkoxy group and geminal disubstitution); wherein Rv is hydrogen or (1-4C)alkyl; or
R4 is selected from one of the groups (TAba) to (TAbc) below, or one of R4 and R5 is selected from the above list of R4 and R5 values, and the other is selected from one of the groups (TAba) to (TAbc) below:
(TAba) a group of the formula (TAba1)

OG Complex Work Unit Drawing
wherein Z0 is hydrogen or (1-4C)alkyl;
X0 and Y0 are independently selected from hydrogen, (1-4C)alkyl, (1-4C)alkoxycarbonyl, halo, cyano, nitro, (1-4C)alkylS(O)q— (q is 0, 1, or 2), RvRwNSO2—, trifluoromethyl, pentafluoroethyl, (1-4C)alkanoyl, and —CONRvRw [wherein Rv is hydrogen or (1-4C)alkyl; Rw is hydrogen or (1-4C)alkyl]; or one of X0 and Y0 is selected from the above list of X0 and Y0 values, and the other is selected from phenyl, phenylcarbonyl, —S(O)q-phenyl (q is 0, 1, or 2), N-(phenyl)carbamoyl, phenylaminosulfonyl, AR2, (AR2)-CO—, (AR2)-S(O)q— (q is 0, 1, or 2), N-(AR2)carbamoyl, and (AR2)aminosulfonyl; wherein any phenyl group in (TAba) may be optionally substituted with up to three substituents independently selected from (1-4C)alkyl, cyano, trifluoromethyl, nitro, halo, and (1-4C)alkylsulfonyl;
(TAbb) an acetylene of the formula —≡—H or —≡-(1-4C)alkyl;
(TAbc) —X1—Y1-AR2, —X1—Y1-AR2a, —X1—Y1-AR2b, —X1—Y1-AR3, —X1—Y1-AR3a, or —X1—Y1-AR3b;
X1 is a direct bond or —CH(OH)—; and Y1 is —(CH2)m—, —(CH2)n—NH—(CH2)m—, —CO—(CH2)m—, —CONH—(CH2)m—, —C(═S)NH—(CH2)m—, or —C(═O)O—(CH2)m—; or
X1 is —(CH2)n— or —CH(Me)-(CH2)m— and Y1 is —(CH2)m—NH—(CH2)m—, —CO—(CH2)m—, —CONH—(CH2)m—, —C(═S)NH—(CH2)m—, —C(═O)O—(CH2)m or —S(O)q—(CH2)m—; or
X1 is —CH2O—, —CH2NH—, or —CH2N((1-4C)alkyl)-; and Y1 is —CO(CH2)m—, —CONH—(CH2)m—, or —C(═S)NH—(CH2)m—;
with the following provisos; Y1 is —SO2— when X1 is —CH2NH— or —CH2N((1-4C)alkyl)-, and
Y1 is —(CH2)m— when X1 is —CH2O— or —CH2N((1-4C)alkyl)-; wherein n is 1, 2, or 3; m is 0, 1, 2, or 3 and q is 0, 1, or 2; and when Y1 is —(CH2)m—NH—(CH2)m— each m is independently selected from 0, 1, 2, or 3;
(TB) T is selected from halo, formyl, or —NRv1Rw1; or is selected from the following groups: (TBa) R10CO—, R10S(O)q— (q is 0, 1, or 2) or R10CS—wherein R10 is selected from the following groups:
(TBaa) -CY1 or CY2;
(TBab) (1-4C)alkoxycarbonyl, trifluoromethyl, —NRvRw, ethenyl, 2-(1-4C)alkylethenyl, 2-cyanoethenyl, 2-cyano-2-((1-4C)alkyl)ethenyl, 2-nitroethenyl, 2-nitro-2-((1-4C)alkyl)ethenyl, 2-((1-4C)alkylaminocarbonyl)ethenyl, 2-((1-4C)alkoxycarbonyl)ethenyl, 2-(AR1)ethenyl, or 2-(AR2)ethenyl; and
(TBac) (1-4C)alkyl {optionally substituted with one or more groups each independently selected from hydroxy, (1-4C)alkoxy, (1-4C)alkanoyl, cyano, halo, trifluoromethyl, (1-4C)alkoxycarbonyl, —NRvRw, (1-6C)alkanoylamino, (1-4C)alkoxycarbonylamino, N-(1-4C)alkyl-N-(1-6C)alkanoylamino, (1-4C)alkylS(O)q— (q is 0, 1, or 2), CY1, CY2, AR1, (1-4C)alkylS(O)pNH—, or (1-4C)alkylS(O)p-((1-4C)alkyl)N— (p is 1 or 2)}; wherein Rv is hydrogen or (1-4C)alkyl; Rw is hydrogen or (1-4C)alkyl; Rv1 is hydrogen, (1-4C)alkyl, or (3-8C)cycloalkyl; Rw1 is hydrogen, (1-4C)alkyl, (3-8C)cycloalkyl, formyl, (1-4C)alkyl-CO—, or (1-4C)alkylS(O)q— (q is 1, or 2);
(TC) T is

OG Complex Work Unit Drawing
wherein in (TC4): n1 is 1 or 2; o1 is 1 or 2, and n1+o1=2 or 3; >A3-B3— is >C═C(Rr)-, >C(Rq)-CH(Rr)-, or >N—CH2—, and G is —O—, —S—, —SO—, —SO2—, or >N(Rc); Rp is hydrogen, (1-4C)alkyl (other than when such substitution is defined by >A3-B3—), hydroxy, (1-4C)alkoxy, or (1-4C)alkanoyloxy;
wherein in (TC4); m1; n1, and o1 are as defined hereinbefore in (TC):
>A3-B3— is >N—CH2—, and G is >C(R11)(R12), >C═O, >C—OH, >C—(1-4C)alkoxy, >C═N—OH, >C═N-(1-4C)alkoxy, >C═N—NH-(1-4C)alkyl, >C═N—N((1-4C)alkyl)2 (the last two (1-4C)alkyl groups above in G being optionally substituted with hydroxy), or >C═N—N—CO-(1-4C)alkoxy;
Rq is hydrogen, hydroxy, halo, (1-4C)alkyl, or (1-4C)alkanoyloxy;
Rr is independently hydrogen or (1-4C)alkyl;
R11 is hydrogen, (1-4C)alkyl, fluoro(1-4C)alkyl, (1-4C)alkyl-thio-(1-4C)alkyl, or hydroxy-(1-4C)alkyl, and R12 is —[C(Rr)(Rr)]m2—N(Rr)(Rc) wherein m2 is 0, 1, or 2;
wherein Rc is selected from groups (Rc1) to (Rc5):
(Rc1) (1-6C)alkyl {optionally substituted with one or more (1-4C)alkanoyl groups (including geminal disubstitution) or optionally monosubstituted with cyano, (1-4C)alkoxy,trifluoromethyl, (1-4C)alkoxycarbonyl, phenyl (optionally substituted as AR1), or (1-4C)alkylS(O)q— (q is 0, 1, or 2); or, on any but the first carbon atom of the (1-6C)alkyl chain, optionally substituted with one or more groups (including geminal disubstitution) each independently selected from hydroxy and fluoro, or optionally monosubstituted with oxo or —NRvRw [wherein Rv is hydrogen or (1-4C)alkyl; Rw is hydrogen, (1-4C)alkyl], (1-6C)alkanoylamino, (1-4C)alkoxycarbonylamino, N-(1-4C)alkyl-N-(1-6C)alkanoylamino, (1-4C)alkylS(O)pNH—, or (1-4C)alkylS(O)p-((1-4C)alkyl)N-(p is 1 or 2)};
(Rc2) formyl, R13CO—, R13SO2—, or R13CS—
wherein R13 is selected from (Rc2a) to (Rc2e):
(Rc2a) AR1, AR2, AR2a, AR2b, AR3, AR3a, AR3b, AR4, AR4a, CY1, or CY2;
(Rc2b) (1-4C)alkoxycarbonyl, trifluoromethyl, —NRvRw [wherein Rv is hydrogen or (1-4C)alkyl; Rw is hydrogen or (1-4C)alkyl], ethenyl, 2-(1-4C)alkylethenyl, 2-cyanoethenyl, 2-cyano-2-((1-4C)alkyl)ethenyl, 2-nitroethenyl, 2-nitro-2-((1-4C)alkyl)ethenyl, 2-((1-4C)alkylaminocarbonyl)ethenyl, 2-((1-4C)alkoxycarbonyl)ethenyl, 2-(AR1)ethenyl, 2-(AR2)ethenyl, or 2-(AR2a)ethenyl;
(Rc2c) (1-10C)alkyl {optionally substituted with one or more groups (including geminal disubstitution) each independently selected from hydroxy, (1-10C)alkoxy, (1-4C)alkoxy-(1-4C)alkoxy, (1-4C)alkoxy-(1-4C)alkoxy-(1-4C)alkoxy, (1-4C)alkanoyl, carboxy, phosphoryl [—O—P(O)(OH)2, and mono- and di-(1-4C)alkoxy derivatives thereof], phophoryl [—O—P(OH)2 and mono- and di-(1-4C)alkoxy derivatives thereof], and amino; or optionally substituted with one group selected from phosphonate[phosphono, —P(O)(OH)2, and mono- and di-(1-4C)alkoxy derivatives thereof], phosphinate [—P(OH)2 and mono- and di-(1-4C)alkoxy derivatives thereof], cyano, halo, trifluoromethyl, (1-4C)alkoxycarbonyl, (1-4C)alkoxy-(1-4C)alkoxycarbonyl, (1-4C)alkoxy-(1-4C)alkoxy-(1-4C)alkoxycarbonyl, (1-4C)alkylamino, di((1-4C)alkyl)amino, (1-6C)alkanoylamino, (1-4C)alkoxycarbonylamino, N-(1-4C)alkyl-N-(1-6C)alkanoylamino, (1-4C)alkylaminocarbonyl, di((1-4C)alkyl)aminocarbonyl, (1-4C)alkylS(O)pNH—, (1-4C)alkylS(O)p-((1-4C)alkyl)N—, fluoro(1-4C)alkylS(O)pNH—, fluoro(1-4C)alkylS(O)p((1-4C)alkyl)N—, (1-4C)alkylS(O)q— [the (1-4C)alkyl group of (1-4C)alkylS(O)q— being optionally substituted with one substituent selected from hydroxy, (1-4C)alkoxy, (1-4C)alkanoyl, phosphoryl [—O—P(O)(OH)2, and mono- and di-(1-4C)alkoxy derivatives thereof], phophoryl [—O—P(OH)2 and mono- and di-(1-4C)alkoxy derivatives thereof], amino, cyano, halo, trifluoromethyl, (1-4C)alkoxycarbonyl, (1-4C)alkoxy-(1-4C)alkoxycarbonyl, (1-4C)alkoxy-(1-4C)alkoxy-(1-4C)alkoxycarbonyl, carboxy, (1-4C)alkylamino, di((1-4C)alkyl)amino, (1-6C)alkanoylamino, (1-4C)alkoxycarbonylamino, N-(1-4C)alkyl-N-(1-6C)alkanoylamino, (1-4C)alkylaminocarbonyl, di((1-4C)alkyl)aminocarbonyl, (1-4C)alkylS(O)pNH—, (1-4C)alkylS(O)p-((1-4C)alkyl)N—, (1-4C)alkylS(O)q—, AR1-S(O)q—, AR2-S(O)q—, AR3-S(O)q—, and AR2a, AR2b, AR3a, and AR3b versions of AR2 and AR3 containing groups], CY1, CY2, AR1, AR2, AR3, AR1-O—, AR2-O—, AR3-O—, AR1-S(O)q—, AR2-S(O)q—, AR3-S(O)q—, AR1-NH—, AR2-NH—, AR3-NH— (p is 1 or 2 and q is 0, 1, or 2), and AR2a, AR2b, AR3a, and AR3b versions of AR2 and AR3 containing groups};
(Rc2d) R14C(O)O(1-6C)alkyl wherein R14 is AR1, AR2, (1-4C)alkylamino (the (1-4C)alkyl group being optionally substituted with (1-4C)alkoxycarbonyl, carboxy), benzyloxy-(1-4C)alkyl, or (1-10C)alkyl {optionally substituted as defined for (Rc2c)};
(Rc2e) R15O— wherein R15 is benzyl, (1-6C)alkyl {optionally substituted as defined for (Rc2c)}, CY1, CY2, or AR2b;
(Rc3) hydrogen, cyano, 2-cyanoethenyl, 2-cyano-2-((1-4C)alkyl)ethenyl, 2-((1-4C)alkylaminocarbonyl)ethenyl, 2-((1-4C)alkoxycarbonyl)ethenyl, 2-nitroethenyl, 2-nitro-2-((1-4C)alkyl)ethenyl, 2-(AR1)ethenyl, 2-(AR2)ethenyl, or (Rc3a)

OG Complex Work Unit Drawing
wherein X00 is —OR17, —SR17, —NHR17, or —N(R17)2;
R17 is hydrogen (when X00 is —NHR17 or —N(R17)2), and
R17 is (1-4C)alkyl, phenyl, or AR2 (when X00 is —OR17, —SR17, or —NHR17); and
R16 is cyano, nitro, (1-4C)alkylsulfonyl, (4-7C)cycloalkylsulfonyl, phenylsulfonyl, (1-4C)alkanoyl, or (1-4C)alkoxycarbonyl;
(Rc4) trityl, AR1, AR2, AR2a, AR2b, AR3, AR3a, or AR3b;
(Rc5) RdOC(Re)═CH(C═O)—, RfC(═O)C(═O)—, RgN═C(Rh)C(═O)—, or RiNHC(Rj)=CHC(═O)—, wherein Rd is (1-6C)alkyl; Re is hydrogen or (1-6C)alkyl, or Rd and Re together form a (3-4C)alkylene chain; Rf is hydrogen, (1-6C)alkyl, hydroxy(1-6C)alkyl, (1-6C)alkoxy(1-6C)alkyl, —NRvRw [wherein Rv is hydrogen or (1-4C)alkyl; Rw is hydrogen or (1-4C)alkyl], (1-6C)alkoxy, (1-6C)alkoxy(1-6C)alkoxy, hydroxy(2-6C)alkoxy, (1-4C)alkylamino(2-6C)alkoxy, di-(1-4C)alkylamino(2-6C)alkoxy; Rg is (1-6C)alkyl, hydroxy, or (1-6C)alkoxy; Rh is hydrogen or (1-6C)alkyl; Ri is hydrogen, (1-6C)alkyl, AR1, AR2, AR2a, or AR2b, and Rj is hydrogen or (1-6C)alkyl;
wherein
AR1 is an optionally substituted phenyl or optionally substituted naphthyl;
AR2 is an optionally substituted 5- or 6-membered, fully unsaturated monocyclic heteroaryl ring containing up to four heteroatoms independently selected from O, N and S (but not containing any O—O, O—Se or S—S bonds), and linked via a ring carbon atom, or a ring nitrogen atom if the ring is not thereby quaternised;
AR2a is a partially hydrogenated version of AR2, linked via a ring carbon atom or linked via a ring nitrogen atom if the ring is not thereby quaternised;
AR2b is a fully hydrogenated version of AR2, linked via a ring carbon atom or linked via a ring nitrogen atom;
AR3 is an optionally substituted 8-, 9- or 10-membered, fully unsaturated bicyclic heteroaryl ring containing up to four heteroatoms independently selected from O, N, and S (but not containing any O—O, O—S, or S—S bonds), and linked via a ring carbon atom in either of the rings comprising the bicyclic system;
AR3a is a partially hydrogenated version of AR3, linked via a ring carbon atom, or linked via a ring nitrogen atom if the ring is not thereby quaternised, in either of the rings comprising the bicyclic system;
AR3b is a fully hydrogenated version of AR3, linked via a ring carbon atom, or linked via a ring nitrogen atom, in either of the rings comprising the bicyclic system;
AR4 is an optionally substituted 13- or 14-membered, fully unsaturated tricyclic heteroaryl ring containing up to four heteroatoms independently selected from O, N, and S (but not containing any O—O, O—S, or S—S bonds), and linked via a ring carbon atom in any of the rings comprising the tricyclic system;
AR4a is a partially hydrogenated version of AR4, linked via a ring carbon atom, or linked via a ring nitrogen atom if the ring is not thereby quaternised, in any of the rings comprising the tricyclic system;
CY1 is an optionally substituted cyclobutyl, cyclopentyl, or cyclohexyl ring;
CY2 is an optionally substituted cyclopentenyl or cyclohexenyl ring;
wherein; optional substituents on AR1, AR2, AR2a, AR2b, AR3, AR3a, AR3b, AR4, AR4a, CY1, and CY2 are (on an available carbon atom) up to three substituents independently selected from (1-4C)alkyl {optionally substituted with substituents selected independently from hydroxy, trifluoromethyl, (1-4C)alkyl S(O)q— (q is 0, 1, or 2), (1-4C)alkoxy, (1-4C)alkoxycarbonyl, cyano, nitro, (1-4C)alkanoylamino, —CONRvRw or —NRvRw}, trifluoromethyl, hydroxy, halo, nitro, cyano, thiol, (1-4C)alkoxy, (1-4C)alkanoyloxy, dimethylaminomethyleneaminocarbonyl, di(N-(1-4C)alkyl)aminomethylimino, carboxy, (1-4C)alkoxycarbonyl, (1-4C)alkanoyl, (1-4C)alkylSO2amino, (2-4C)alkenyl {optionally substituted with carboxy or (1-4C)alkoxycarbonyl}, (2-4C)alkynyl, (1-4C)alkanoylamino, oxo (═O), thioxo (═S), (1-4C)alkanoylamino {the (1-4C)alkanoyl group being optionally substituted with hydroxy}, (1-4C)alkyl S(O)q— (q is 0, 1, or 2) {the (1-4C)alkyl group being optionally substituted with one or more groups independently selected from cyano, hydroxy and (1-4C)alkoxy}, —CONRvRw, or —NRvRw [wherein Rv is hydrogen or (1-4C)alkyl; Rw is hydrogen or (1-4C)alkyl];
and further optional substituents on AR1, AR2, AR2a, AR2b, AR3, AR3a, AR3b, AR4, AR4a, CY1, CY2 (on an available carbon atom), and alkyl groups (unless indicated otherwise) are up to three substituents independently selected from trifluoromethoxy, benzoylamino, benzoyl, phenyl {optionally substituted with up to three substituents independently selected from halo, (1-4C)alkoxy or cyano}, furan, pyrrole, pyrazole, imidazole, triazole, pyrimidine, pyridazine, pyridine, isoxazole, oxazole, isothiazole, thiazole, thiophene, hydroxyimino(1-4C)alkyl, (1-4C)alkoxyimino(1-4C)alkyl, halo-(1-4C)alkyl, (1-4C)alkanesulfonamido, or —SO2NRvRw [wherein Rv is hydrogen or (1-4C)alkyl; Rw is hydrogen or (1-4C)alkyl]; and optional substituents on AR2, AR2a, AR2b, AR3, AR3a, AR3b, AR4, and AR4a are (on an available nitrogen atom, where such substitution does not result in quaternization) (1-4C)alkyl, (1-4C)alkanoyl {wherein the (1-4C)alkyl and (1-4C)alkanoyl groups are optionally substituted with substituents independently selected from cyano, hydroxy, nitro, trifluoromethyl, (1-4C)alkyl S(O)q— (q is 0, 1, or 2), (1-4C)alkoxy, (1-4C)alkoxycarbonyl, (1-4C)alkanoylamino, —CONRvRw, or —NRvRw [wherein Rv is hydrogen or (1-4C)alkyl; Rw is hydrogen or (1-4C)alkyl]}, (2-4C)alkenyl, (2-4C)alkynyl, (1-4C)alkoxycarbonyl, or oxo (to form an N-oxide).